Ciclesonide 80 μG or 320 μG once daily achieves lung function improvement comparable with budesonide 200 μG twice daily in patients with persistent asthma

被引：0
|
作者：
Hansel, T [1 ]
Biberger, C [1 ]
Engelstätter, R [1 ]
机构：
[1] Royal Brompton Hosp, London, England
来源：
THORAX | 2004年 / 59卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：71 / 71
页数：1
相关论文
共 50 条
  • [41] Comparison of the efficacy of ciclesonide 160 μg QD and budesonide 200 μg BID in adults with persistent asthma:: A phase III, randomized, double-dummy, open-label study
    Niphadkar, P
    Jagannath, K
    Joshi, JM
    Awad, N
    Boss, H
    Hellbardt, S
    Gadgil, DA
    CLINICAL THERAPEUTICS, 2005, 27 (11) : 1752 - 1763
  • [42] EFFICACY AND SAFETY OF ONCE-DAILY ACLIDINIUM BROMIDE 200 μG IN COMBINATION WITH FORMOTEROL IN PATIENTS WITH COPD
    Sliwinski, P.
    Perng, D-W
    Chuchalin, A.
    Jones, P. W.
    THORAX, 2010, 65 : A136 - A136
  • [43] Efficacy and safety of inhaled budesonide delivered once or twice daily via HFA-134a in mild to moderate persistent asthma in adult patients. Comparison with budesonide CFC
    Vastagh, E
    Kuna, P
    Calistru, P
    Bogdan, MA
    RESPIRATORY MEDICINE, 2003, 97 : S20 - S28
  • [44] A randomised, phase III trial of once-daily fluticasone furoate/vilanterol 100/25 μg versus once-daily vilanterol 25 μg to evaluate the contribution on lung function of fluticasone furoate in the combination in patients with COPD
    Siler, Thomas M.
    Nagai, Atsushi
    Scott-Wilson, Catherine A.
    Midwinter, Dawn A.
    Crim, Courtney
    RESPIRATORY MEDICINE, 2017, 123 : 8 - 17
  • [45] NASAL SYMPTOM IMPROVEMENT FOLLOWING ONCE-DAILY TREATMENT WITH BECLOMETHASONE DIPROPIONATE NASAL AEROSOL (80 μG OR 160 μG) IN CHILDREN WITH SEASONAL ALLERGIC RHINITIS
    Storms, W. W.
    Nayak, N. A.
    Kelley, L.
    Ding, Y.
    Tantry, S. K.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2012, 109 (05) : A131 - A131
  • [46] Nasal symptom improvement following once-daily treatment with beclomethasone dipropionate nasal aerosol (80 μg or 160 μg) in children with seasonal allergic rhinitis
    Storms, W. W.
    Nayak, N. A.
    Kelley, L.
    Ding, Y.
    Tantry, S. K.
    ALLERGY AND ASTHMA PROCEEDINGS, 2013, 34 (03) : 300 - 300
  • [47] Efficacy and safety of fluticasone furoate 100 g and 200 g once daily in the treatment of moderate-severe asthma in adults and adolescents: a 24-week randomised study
    Woodcock, Ashley
    Loetvall, Jan
    Busse, William W.
    Bateman, Eric D.
    Stone, Sally
    Ellsworth, Anna
    Jacques, Loretta
    BMC PULMONARY MEDICINE, 2014, 14
  • [48] Efficacy and safety of fluticasone furoate 100 μg and 200 μg once daily in the treatment of moderate-severe asthma in adults and adolescents: a 24-week randomised study
    Ashley Woodcock
    Jan Lötvall
    William W Busse
    Eric D Bateman
    Sally Stone
    Anna Ellsworth
    Loretta Jacques
    BMC Pulmonary Medicine, 14
  • [49] A 12-week, Randomized, Parallel-group, Phase III Study Comparing the Efficacy of Once-daily Budesonide/formoterol Turbuhaler (160/4.5 mu g/d) with Twice-daily Budesonide (400 mu g/d) During the Step-down Period in Well-controlled Asthma
    Nakwan, Narongwit
    Perkleang, Thitima
    Tamsawai, Thanida
    Taptawee, Pattarawadee
    Usaha, Sirikade
    TURKISH THORACIC JOURNAL, 2018, 19 (02) : 66 - 72
  • [50] COMPARISON OF INHALED BECLOMETHASONE DIPROPIONATE 1000 MU-G TWICE-DAILY AND ORAL PREDNISONE 10 MG ONCE-DAILY IN ASTHMATIC-PATIENTS
    BOSMAN, HG
    VANUFFELEN, R
    TAMMINGA, JJ
    PAANAKKER, LR
    THORAX, 1994, 49 (01) : 37 - 40
12345